PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F42CB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,863
Award facts
- Contract value 100% obligated
- $15,863.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $15,863.04 to AmerisourceBergen Drug Corp on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award is non-competitive set-aside and covers pharmaceutical products and medical supplies to support federal military and healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense Department, with the place of performance located in Conshohocken, PA.
As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen Drug Corp supplies a comprehensive range of medical commodities including brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements through competitive awards and firm fixed-price delivery orders. This delivery order exemplifies AmerisourceBergen's role within the DLA's pharmaceutical procurement strategy, which is transitioning toward the Pharmaceutical Prime Vendor Global Program Generation V to establish multiple regional contracts with enhanced flexibility and comprehensive medical supply capabilities for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2D825F42CB?
SPE2D825F42CB was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2D825F42CB worth?
The government has obligated $15,863 on SPE2D825F42CB.
Is contract SPE2D825F42CB an order under another contract?
Yes. SPE2D825F42CB is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D825F42CB competed?
The extent of competition for SPE2D825F42CB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award